What factors are associated with high-frequency drug treatment use among a racially and ethnically diverse population of injection drug users?

American Journal on Addictions

Volumn 15, Issue 6, 2006, Pages 440-449

  Chassler, Deborah ^a,b   Lundgren, Lena ^a   Lonsdale, Joya ^a  

^a BOSTON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; AGED; ARTICLE; COCAINE DEPENDENCE; DEMOGRAPHY; DRUG DEPENDENCE TREATMENT; DRUG USE; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEROIN DEPENDENCE; HOMELESSNESS; HUMAN; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MULTIPLE REGRESSION; PARENTAL BEHAVIOR; PATIENT COUNSELING; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; SAMPLE SIZE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; CHRONIC DISEASE; COCAINE-RELATED DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; CULTURAL DIVERSITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEROIN DEPENDENCE; HISPANIC AMERICANS; HOMELESS PERSONS; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PATIENT READMISSION; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; UTILIZATION REVIEW;

EID: 33845876633     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490600998500     Document Type: Article

References (32)

1. Hser Y, Huang D, Teruya C, Anglin MD. Diversity of drug abuse treatment utilization patterns and outcomes. Evaluation and Program Planning. 2004;27:309-319.
2. McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447-458.
3. Lee MT, Reif S, Ritter GA, Levine HJ, Horgan CM. Alcohol and Drug Services Study (ADSS) Phase II: Client record abstract report (DHHS Publication No. SMA04-3974, Analytic Series No A-27). Substance Abuse and Mental Health Services Administration. Available at: http://www.drugabusestatistics.samhsa. gov/ADSS/ADSSclientrecordabsw.pdf. Accessed November 1, 2005.
4. Anglin DM, Hser YI, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. Dec 1997;11:308-323.
5. Amodeo M, Chassler D, Ferguson F, Fitzgerald T, Lundgren L. Use of mental health and substance abuse treatment services by female injection drug users. Am J Drug Alcohol Abuse. 2004;30:101-120.
6. Lundgren L, Amodeo M, Ferguson F, Davis K. Racial and ethnic differences in drug treatment entry by injection drug users in Massachusetts: residential treatment versus detoxification only. J Subst Abuse Treat. 2001;21:145-153.
7. Lundgren L, Schilling RF, Ferguson F, Davis K, Amodeo M. Examining drug treatment program entry of injection drug users: human capital and institutional disaffiliation. Evaluation and Program Planning. 2003;26:123-132.
8. Lundgren L, Schilling RF, Sullivan L, Chassler D. Predictors of drug treatment type for women who inject drugs: client characteristics and service access. Unpublished manuscript; 2005.
9. Lundgren L, Chassler D, Ben-Ami L, Purington T, Schilling RF. Factors associated with emergency use among injection drug users of African American, Hispanic, and white European background. Am J Addict. 2005;14:268-280.
10. Scott CK, Foss M, Dennis M. Pathways in the relapse-treatment-recovery cycle over three years. J Subst Abuse Treat. 2005;28:S63-S72.
11. Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Household Survey on Drug Abuse: Main Findings 1998. Rockville, Md.: Substance Abuse and Mental Health Services Administration; 2000.
12. Zule WA, Desmond DP. Factors predicting entry of injecting drug users into substance abuse treatment. Am J Drug Alcohol Abuse. 2000;26:247-261.
13. Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004;74:177-185.
14. Luchansky B, He L, Krupski A, Stark KD. Predicting readmission to substance abuse treatment using state information systems: the impact of client and treatment characteristics. J Subst Abuse. 2000;12:255-270.
15. Weisner C, Matzger H. A prospective study of the factors influencing entry to alcohol and drug treatment. J Behav Health Serv Res. 2002;29:126-137.
16. Schmidt L, Weisner CM. Private insurance and the utilization of chemical dependency treatment. J Subst Abuse Treat. 2005;28:67-76.
17. Shanahan CW, Lincoln A, Horton NJ, Saitz R, Winter M, Samet JH. Relationship of depressive symptoms and mental health functioning to repeat detoxification. J Subst Abuse Treat. 2005;29:117-123.
18. Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Available at: http://alt.samhsa.gov/reports/ congress2002/. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447-458.
19. Substance Abuse and Mental Health Services Administration. National survey on substance abuse treatment services (N-SSATS): 2000 data on substance abuse treatment facilities. DHHS publication no. SMA 02-3668. Rockville, Md.: US Government Printing Office; 2002. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447-458.
20. National Institute on Drug Abuse. Principles of drug addiction treatment: a research-based guide. NIH publication no. 00-4180. NIDA. Available at: http://165.112.78.61/PODAT/PODATindex. html. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447-458.
21. Hser Y, Grella CE, Hsieh S, Anglin MD, Brown BS. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57:137-150.
22. Grella CE, Hser Y, Hsieh S. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. J Subst Abuse Treat. 2003;25:145-154.
23. Cacciola JS, Dugosh K, Foltz C, Leahy P, Stevens R. Treatment outcomes: first time versus treatment-experienced clients. J Subst Abuse Treat. 2005;28:S13-S22.
24. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689-1695.
25. Lundgren L, Schilling RF, Ferguson F, Amodeo M. Parental status of women injection drug users and entry to methadone maintenance. Subst Use Misuse. 2003;38:1109-1131.
26. McMahon TJ, Winkel JD, Suchman NE, Luthar SS. Drug dependence, parenting responsibilities, and treatment history: why doesn't mom go for help? Drug Alcohol Depend. 2002;65:105-114.
27. Dennis ML, Scott CK, Funk R, Foss MA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28:S51-S62.
28. McLellan T. Have we evaluated addiction treatment correctly? implications from a chronic care perspective. Addiction. 2002;97:249-252.
29. McCarty D, McGuire TG, Harwood HJ, Field T. Using state information systems for drug abuse services research. American Behavioral Scientist. 1998;41:1090-1106.
30. Lundgren LM, Sullivan L, Amodeo M. How do treatment repeaters use the drug treatment system? an analysis of injection drug users in Massachusetts. J Subst Abuse Treat. 2006;30:121-128.
31. Simpson DD. A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat. 2004;27:99-121.
32. Simpson DD, Joe GW. A longitudinal evaluation of treatment engagement and recovery stages. J Subst Abuse Treat. 2004;27:89-97.